Mannheim, Germany

Rudolf Machat

This inventor holds 2 USPTO granted patents. Top assignee: Boehringer Mannheim Gmbh. Active years: 1987-1991.


% Patents Active = 100.0

Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1987-1991

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Rudolf Machat: Innovator in Glycoside Research

Introduction

Rudolf Machat is a notable inventor based in Mannheim, Germany. He has made significant contributions to the field of glycoside research, particularly in the enrichment and isolation of heart glycosides. His work has led to the development of innovative diagnostic agents that have potential applications in medicine.

Latest Patents

Rudolf Machat holds 2 patents. His latest patents include a process for the enrichment and/or isolation of heart glycosides using phenolsulphonphthaleinyl-.beta.-D-galactosides. This invention provides phenolsulphonphthaleinyl-.beta.-D-galactosides of a specific general formula, where various groups can be hydrogen, halogen atoms, or functional groups such as nitro or amino. Additionally, the invention outlines a process for preparing these galactosides and the diagnostic agents that contain them.

Career Highlights

Rudolf Machat is associated with Boehringer Mannheim GmbH, where he has contributed to various research projects. His work has been instrumental in advancing the understanding of glycosides and their applications in diagnostics.

Collaborations

Some of his notable coworkers include Wolfgang Weckerle and Carl H. Ross. Their collaborative efforts have further enhanced the research and development of innovative solutions in the field.

Conclusion

Rudolf Machat's contributions to glycoside research and his innovative patents highlight his role as a significant inventor in the field. His work continues to influence advancements in medical diagnostics and treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…